July 27, 2017 – Free Executive Web Briefing Sponsored By Otsuka Pharmaceutical Development & Commercialization, Inc.s Frameworks In Health & Quality Program
Major Depressive Disorder (MDD) is estimated to affect over 16% of the U.S. population over the course of their lifetime.1 It is often co-occurring with chronic medical conditions like diabetes or cardiovascular disease, as well as with other mental illnesses such as anxiety and substance use disorders. 2, 3 Treating MDD with a collaborative approach has been shown to improve care quality and outcomes, and to reduce costs.4,5,6
Join Heidi Waters, PhD, Director of Outcomes Management at Otsuka Pharmaceutical Development & Commercialization, Inc. and a co-presenter on July 27 at 2:00 p.m. ET to hear about the Frameworks In Health & Quality disease management program focusing on collaborative care for MDD. Faculty will also explore statistics of MDD, and how to use a collaborative approach in treating MDD.
During this 90-minute web briefing, attendees will:
- Understand the impact of MDD on consumer’s lives and their use of health care resources
- Explore ‘best practice’ collaborative approaches to supporting consumers MDD –and how these approaches may improve care quality and outcomes
- Participate in a discussion with our co-presenters on their experience addressing the needs of consumers
The co-presenter is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
1. Kessler RC, Berglund P, Demler O, et al.
2. Gelenberg AJ, Freeman MP, Markowitz JC, et al, for the Work Group on Major Depressive Disorder, American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder. II. Formulation and Implementation of a Treatment Plan. Arlington, VA: American Psychiatric Publishing, Inc.; 2004.
3. Chapman DP, Perry GS, Strine TW. The vital link between chronic disease and depressive disorders. Prev Chronic Dis. 2005;2(1):1-10.
4. Butler M, Kane RL, McAlpine D, et al. Integration of Mental Health/Substance Abuse and Primary Care. Evidence Reports/Technology Assessments, No. 173. Rockville, MD: Agency for Healthcare Research and Quality; October 2008.
5. Katon W, von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA. 1995;273;13:1026-1031.
6. Unützer J, Harbin H, Schoenbaum M, Druss B. The Collaborative Care Model: An Approach for Integrating Physical and Mental Health Care in Medicaid Health Homes. Hamilton, NJ: Centers for Medicare & Medicaid Services, Center for Health Care Strategies and Mathematica Policy Research; May 2013
© 2017 Otsuka Pharmaceutical Development & Commercialization, Inc. April 2017 MRC2.UNB.X.00129